10-Q: Antiaging Quantum Living Inc. Reports Q3 2024 Results with Increased Losses Amidst Business Expansion
Quarterly Report
Antiaging Quantum Living Inc. reported increased net losses for the third quarter of 2024, driven by higher operating expenses related to business expansion, despite a slight increase in revenue.
Summary
- Antiaging Quantum Living Inc. reported a net loss of $97,090 for the three months ended December 31, 2023, compared to a net loss of $6,772 for the same period in 2022.
- The company's revenue increased to $6,299 for the quarter, up from $4,000 in the prior year.
- Operating expenses significantly increased to $102,632, compared to $10,772 in the same quarter of the previous year.
- For the nine months ended December 31, 2023, the company's net loss was $151,196, compared to a net loss of $29,397 for the same period in 2022.
- The company's revenue for the nine-month period was $7,499, down from $12,400 in the prior year.
- Operating expenses for the nine-month period totaled $147,251, compared to $41,797 in the prior year.
- The company's accumulated deficit was $427,527 as of December 31, 2023.
- The company had cash and cash equivalents of $125,648 and negative working capital of $542,859 as of December 31, 2023.
- The company has two operating leases for office space with a weighted average remaining lease term of 2 years and an average discount rate of 4.75%.
Sentiment
Score: 3
Explanation: The document indicates significant financial challenges, including increased losses, negative working capital, and doubts about the company's ability to continue as a going concern. The company also has material weaknesses in internal controls. While there are some positives, such as increased revenue in the last quarter, the overall sentiment is negative.
Positives
- The company's revenue increased in the three months ended December 31, 2023, compared to the same period in 2022.
- The company has secured loans payable of $427,675 from unrelated third parties.
- The company received $371,369 in advances from the President for working capital.
Negatives
- The company experienced a significant increase in net losses for both the three and nine-month periods ending December 31, 2023.
- Operating expenses increased substantially in both the three and nine-month periods ending December 31, 2023.
- The company's revenue decreased for the nine months ended December 31, 2023, compared to the same period in 2022.
- The company has a negative working capital of $542,859 as of December 31, 2023.
- The company has an accumulated deficit of $427,527 as of December 31, 2023.
Risks
- The company's ability to continue as a going concern is in doubt due to negative financial trends, including cash outflow from operating activities, operating losses, and an accumulated deficit.
- The company's disclosure controls and procedures were not effective at a reasonable assurance level due to material weaknesses in internal control over financial reporting.
- The company's internal controls over financial reporting have material weaknesses, including a lack of US GAAP knowledge and segregation of duties.
- The company's future success depends on its ability to improve business profitability and generate sufficient cash flow from operations.
- The company's ability to obtain additional working capital funds from the majority shareholder is not guaranteed.
Future Outlook
The company intends to improve its business profitability, generate sufficient cash flow from operations, and obtain additional working capital funds from the majority shareholder to meet its operating needs. The company is also attempting to consummate a business combination.
Management Comments
- Management believes that the application of these policies on a consistent basis enables us to provide useful and reliable financial information about our operating results and financial condition.
- Management's plan to alleviate the substantial doubt about the Company's ability to continue as a going concern include attempts to consummate a business combination and to generate sufficient cash flow from its operations to meet its operating needs on a timely basis; as well as to obtain additional working capital funds as loans from the majority shareholder and the President of the Company.
Industry Context
The company's expansion into healthcare management and insurance services reflects a broader trend of companies diversifying into these sectors. The company's focus on e-commerce platforms and personalized marketing aligns with the growing importance of digital channels in the health and wellness industry.
Comparison to Industry Standards
- The company's significant increase in operating expenses and net losses is concerning when compared to industry standards for companies in the early stages of expansion.
- The company's negative working capital and accumulated deficit are also below industry benchmarks for companies of similar size and stage.
- The company's reliance on shareholder loans for working capital is not a sustainable long-term strategy and is not typical of established companies in the healthcare and insurance sectors.
- The company's lack of effective internal controls over financial reporting is a significant deficiency compared to industry best practices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President, CEO, Director | Dingshan Zhang | Jing Wan | 2023-04-10 | Change of control of the company |
| CEO, CFO | Jing Wan | Barry Wan | 2023-06-16 | Resignation of Jing Wan |
Related Party Transactions
- The company received advances in the total amount of $371,369 from Mr. Wan, our President for working capital purpose.
- A shareholder loan in the amount of $83,300 was forgiven by the former President and recorded as additional paid-in capital.
Stakeholder Impact
- Shareholders face increased risk due to the company's financial instability and going concern issues.
- Employees may be impacted by potential cost-cutting measures or restructuring.
- Customers may be affected by changes in the company's operations or product offerings.
- Suppliers may face uncertainty regarding payment for goods and services.
- Creditors face increased risk of non-payment due to the company's financial difficulties.
Next Steps
- The company plans to improve its business profitability.
- The company plans to generate sufficient cash flow from operations.
- The company plans to obtain additional working capital funds from the majority shareholder.
- The company is attempting to consummate a business combination.
Key Dates
| Date | Description |
|---|---|
| 2014-12-29 | Antiaging Quantum Living Inc. was incorporated in New York. |
| 2019-07-01 | Change of control of the company with Dingshan Zhang appointed as President and CEO. |
| 2023-04-10 | Barry Wan acquired control of the company, Dingshan Zhang resigned, and Jing Wan was appointed as CEO, CFO, President and Director. |
| 2023-06-14 | The company was renamed Antiaging Quantum Living Inc. |
| 2023-06-16 | Barry Wan consented to act as the new CEO and CFO after Jing Wan resigned. |
| 2023-11-13 | Antiaging Doctor Hangzhou Holding LTD was incorporated in China. |
| 2023-11-30 | Dao Ling Doctor (Zhejiang) Health Management Limited was incorporated in China. |
| 2023-12-06 | Dao Ling Doctor (Huzhou) Health Management Limited was incorporated in China. |
| 2023-12-31 | End of the reporting period for the quarterly report. |
| 2024-02-14 | Date of the report filing. |
Keywords
financial results, net loss, operating expenses, revenue, working capital, going concern, internal controls, healthcare management, insurance services, lease liabilities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.